STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] HeartBeam, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HeartBeam, Inc. (BEAT) CFO Tim Cruickshank reported a Form 4 showing a sale of 17,647 shares of Common Stock and a grant of 23,333 Restricted Stock Units (RSUs) on 09/30/2025. The RSUs were issued under the company’s 2022 Equity Incentive Plan and vest in two equal tranches: one half on the three‑month anniversary of the vesting commencement date (July 1, 2025 start) and the remainder on the six‑month anniversary. The filing notes RSUs do not expire and are either vested or canceled. The report was signed by the reporting person on 10/03/2025.

Positive

  • 23,333 RSUs granted under the 2022 Equity Incentive Plan, aligning executive compensation with shareholders
  • RSU vesting schedule is time‑based with clear dates (three‑ and six‑month anniversaries), providing transparency

Negative

  • 17,647 shares disposed by the CFO, representing an insider sale disclosed on Form 4
  • Immediate insider sale and near‑term vesting could increase free float in the short term

Insights

TL;DR: CFO sold 17,647 shares and received 23,333 RSUs vesting over 3–6 months.

The Form 4 documents two distinct actions: a disposal of 17,647 common shares and a grant of 23,333 RSUs under the 2022 Equity Incentive Plan. The RSUs vest in two equal installments tied to a vesting commencement date of July 1, 2025, with no listed expiration.

This filing is material to shareholders because it records immediate insider selling and a near‑term equity compensation schedule for a senior officer; both items are factual disclosures required by Section 16 and may affect short‑term share count and insider ownership disclosure.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Cruickshank Tim

(Last) (First) (Middle)
2118 WALSH AVE
SUITE 210

(Street)
SANTA CLARA CA 95050

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 17,647 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Award $0 (1) (2) Common Stock 23,333 23,333 D
Explanation of Responses:
1. Granted Restricted Stock Units (RSU's) on September 30, 2025, one half of the total number of Shares subject to the Special RSU shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares subject to the Special RSU shall vest on the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.
2. RSUs do not expire, they either vest or are canceled prior to vesting date
Remarks:
/s/ Tim Cruickshank 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HeartBeam CFO Tim Cruickshank report on Form 4 (BEAT)?

The Form 4 reports a disposal of 17,647 common shares and a grant of 23,333 RSUs on 09/30/2025.

What is the vesting schedule for the RSUs reported in the BEAT Form 4?

The RSUs vest in two equal tranches: one half on the three‑month anniversary and the remainder on the six‑month anniversary of the vesting commencement date (July 1, 2025).

Under which plan were the RSUs issued?

The RSUs were issued under the company’s 2022 Equity Incentive Plan.

Do the RSUs reported for BEAT expire?

The filing states that the RSUs do not expire; they either vest or are canceled prior to vesting.

When was the Form 4 signed?

The Form 4 was signed by Tim Cruickshank on 10/03/2025.
Heartbeam Inc

NASDAQ:BEAT

BEAT Rankings

BEAT Latest News

BEAT Latest SEC Filings

BEAT Stock Data

22.73M
26.28M
23.8%
10.48%
0.36%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA